Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of sorafenib and 5-azacitidine in patients with acute myeloid leukemia and myelodysplastic syndro…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies [Phase 1]
Phase 1 study evaluating TG02 Citrate in patients with advanced hematologic malignancies has completed, including AML, ALL, blast crisis, MD…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias
This entry provides an update on a haploidentical hematopoietic stem cell transplantation trial for acute leukemias, with the current status…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation [Phase 2]
Phase 2 clinical trial evaluating repeat transplantation for relapsed or refractory hematologic malignancies after prior transplant; the stu…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Clinical trial update on memory T-cell infusion after TCR-alpha/beta depleted hematopoietic stem cell transplantation, with Phase 1/2 status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: TevaGastrim for Stem Cell Mobilization Sibling Donors [Phase 2]
This Phase 2 clinical trial update reports the completion of a study evaluating TevaGastrim for stem cell mobilization in sibling donors for…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer [Phase 1]
A Phase I clinical trial is evaluating an oncofetal antigen multi-peptide immunotherapy in hematologic cancers, including acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial testing belinostat and bortezomib in relapsed or refractory acute leukemias and myelodysplastic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
This SWOG clinical trial update reports a completed study investigating DNA analyses in samples from patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia [Phase 1]
A Phase 1 study evaluating LOP628 in adults with c-KIT–positive solid tumors and acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML) [Phase 3]
This clinical trial update summarizes a Phase 3 study evaluating remission-induction therapy followed by a risk-oriented postremission strat…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial examining idarubicin + cytarabine with lenalidomide for myelodysplastic syndrome and acute myeloid leukemia has completed wi…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia [Phase 1, Phase 2]
Clinical trial update indicates that the Phase 1/2 safety study of AKN-028 in Acute Myeloid Leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL [Phase 1, Phase 2]
A phase 1/2 trial evaluating an allogeneic stem cell transplant regimen using clofarabine, cytarabine (Ara-C), and total body irradiation fo…
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating pre-emptive azacitidine and donor lymphocyte infusions after allogeneic stem cell transplantation for high-risk acu…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Lenalidomide Plus Chemotherapy for AML [Phase 1]
A Phase 1 trial evaluating lenalidomide in combination with chemotherapy for acute myeloid leukemia has been completed.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR) [Phase 2]
This update summarizes results from a Phase 2 trial evaluating maintenance therapy in elderly patients with acute myeloid leukemia after ach…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia [Phase 1]
Phase 1 study of Plerixafor plus Granulocyte-colony Stimulating Factor in relapsed Acute Myeloid Leukemia was terminated. The trial status i…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1]
Phase I study of CWP232291 in patients with acute myeloid leukemia and related myeloid neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
Clinical trial update on the use of decitabine for chemotherapy-unfit elderly patients with acute myeloid leukemia in real-world Korean prac…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies [Phase 2]
Phase 2 trial of Brentuximab Vedotin in CD30-positive non-lymphomatous malignancies has completed and results were posted in 2016. The study…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649) [Phase 1]
Phase 1 trial of MK-8242 alone and with cytarabine in adults with acute myeloid leukemia (AML) was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma [Phase 1]
Phase 1 trial of a cancer vaccine therapy with GM-CSF in patients with acute myeloid leukemia, myelodysplastic syndromes, non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
This update reports the completion of Phase 1 and Phase 2 clinical trials evaluating dasatinib (Sprycel) in newly diagnosed core-binding fac…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial evaluating clofarabine with low-dose cytarabine induction followed by decitabine consolidation in frontline acute myeloid leuk…